Abstract
Foreword
1 Epidemiology of diabetes in China
1.1 Trend of Epidemiology and current status
1.2 Examples of Epidemiology investigation
1.3 Etiological factors in China
2 Categories and action mechanisms of antidiabetic drugs
2.1 Categories
2.2 Action mechanisms
2.3 Marketed breeds in China
2.4 Breeds adopted in catalogue of Drugs for Basic National Medical Insurance
3 Market analysis of antidiabetic drugs
3.1 Market scale and category share
3.2 Leading breeds last year last year
3.3 Leading enterprises last year
3.4 Market analysis of sulfonylurea class
3.4.1 Glipizide
3.4.2 Gliquidone
3.4.3 Gliclazide
3.4.4 Glimepiride
3.4.5 Glibenclamide
3.4.6 Tolbutamide
3.5 Market analysis of biguanides class
3.5.1 sales value
3.5.2 Breakdown of Metformin
3.6 α-glucosidase inhibitor
3.6.1 Acarbose
3.6.2 Voglibose
3.7 Insulin sensitizer
3.8 Insulin secretagogues
3.8.1 Repaglinide
3.8.2 Nateglinide
3.9 Insulin class
3.10 Prepared Chinese Medicine
3.11 General trend of oral antidiabetic drugs
4 Research and development in China
4.1 List of Domestic marketd products and import procucts
4.2 Status of application and approval
中文
